Business Practice

Is waiving patents for COVID-19 vaccines the right step forward?

Implementing sustainable practices for a better future.

A report suggests that more needs to be done to combat bleeding disorders. Is pharma playing its part in addressing this issue?

How do we vaccinate billions of people? “Nobody wins the race until everyone wins.”

What factors influence the public’s perception of the pharmaceutical industry?

COVID-19 has put the spotlight on the weaknesses of today’s highly dispersed, globalized pharma industry. Is onshoring the answer?

How has COVID-19 consumer stockpiling affected the supply chains for pharma ingredients?

Abcam explains how giving workers more flexibility has been good for the business.

According to Gavi, “Developing a vaccine against COVID-19 is the most pressing challenge of our time – and nobody wins the race until everyone wins.”

mVaccination is a mobile platform transforming COVID-19 vaccine distribution.